Status:
WITHDRAWN
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Lead Sponsor:
Santhera Pharmaceuticals
Conditions:
Leber's Hereditary Optic Neuropathy
Eligibility:
All Genders
10-65 years
Phase:
PHASE3
Brief Summary
The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Eligibility Criteria
Inclusion
- Age \> or equal 10 years and \< 65 years
- Impaired visual acuity in affected eyes due to LHON: Visual acuity in best eye \>0.4 logMAR
- No explanation for visual loss besides LHON
Exclusion
- Any previous use of idebenone
- Participation in another clinical trial of any investigational drug within 3 months prior to Baseline
- Previous participation in Study SNT-II-003 (RHODOS) for idebenone.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01495715
Last Update
August 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.